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Canonical Wnt/b-Catenin Signaling Is Required
for Maintenance But Not Activation of Pitx2
Expression in Neural Crest During Eye
Development
Amanda L. Zacharias and Philip J. Gage*
Pitx2 is a paired-like homeodomain gene that acts as a key regulator of eye development. Despite its signifi-
cance, upstream regulation of Pitx2 expression during eye development remains incompletely understood.
We use neural crest-specific ablation of Ctnnb1 to demonstrate that canonical Wnt signaling is not required
for initial activation of Pitx2 in neural crest. However, canonical Wnt signaling is subsequently required to
maintain Pitx2 expression in the neural crest. Eye development in Ctnnb1-null mice appears grossly normal
early but significant phenotypes emerge following loss of Pitx2 expression. LEF-1 and b-catenin bind Pitx2
promoter sequences in ocular neural crest, indicating a likely direct effect of canonical Wnt signaling on
Pitx2 expression. Combining our data with previous reports, we propose a model wherein a sequential code
of retinoic acid followed by canonical Wnt signaling are required for activation and maintenance of Pitx2
expression, respectively. Other key transcription factors in the neural crest, including Foxc1, do not require
intact canonical Wnt signaling. Developmental Dynamics 239:3215–3225, 2010. VC 2010 Wiley-Liss, Inc.
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INTRODUCTION
It is a well-established paradigm that
the net expression patterns of impor-
tant developmental transcriptional
regulators result from the integration
of multiple inductive signaling inputs,
but the underlying molecular details
are poorly understood in most sys-
tems. The mammalian eye provides an
excellent system for further detailed
analysis of this model because exten-
sive inductive signaling contributed
by multiple major signaling pathways
is passed back and forth between the
four embryonic primordial contribut-
ing to the mature organ. For example,
inductive signaling from the neuroec-
toderm-derived optic vesicle is
required for initiation of the lens dif-
ferentiation program in the overlying
surface ectoderm and the newly
induced lens placode in turn signals
back to the optic vesicle, specifying
the position where the presumptive
retina will emerge within the neuro-
ectoderm (Chow and Lang, 2001).
Development of the ocular anterior
segment, including the cornea, limbus,
conjunctiva, eyelids, and ciliary body,
is particularly complex. It requires the
interaction of neuroectoderm, surface
ectoderm, and neural crest and meso-
derm mesenchyme. The mature cor-
nea, limbus, conjunctiva, eyelids, and
ciliary body are chimeric, arising from
an integration of neuroectoderm (cili-
ary body) or surface ectoderm (cornea,
limbus, conjunctiva, and eyelids) and
mesenchyme. Development of the pri-
mordia to these structures commences
immediately after transition of the
optic vesicle to the optic cup and sepa-
ration of the lens vesicle from the sur-
face ectoderm, when mesenchyme cells
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consisting primarily of neural crest
begin to migrate between the anterior
optic cup/lens vesicle and the overlying
surface ectoderm (Cvekl and Tamm,
2004; Gould et al., 2004). Retinoic acid
(RA) signaling from the optic cup, lens,
and surface ectoderm crest plays a
critical role in orchestrating the mor-
phogenesis of the anterior segment at
this stage of development by activating
expression of key transcription factor
genes in the neural crest (Matt et al.,
2005, 2008; Molotkov et al., 2006).
A critical downstream target of RA
signaling in the ocular neural crest at
this stage is the homeobox gene, Pitx2
(Matt et al., 2005, 2008; Molotkov
et al., 2006). Global or neural crest–
specific loss of Pitx2 in mice results in
severe dysmorphogenesis of the eye,
including loss of any recognizable ante-
rior segment structures except the lens
(Gage et al., 1999; Evans and Gage,
2005). These defects closely phenocopy
those found in mice in which RA sig-
naling is disrupted, in part because
Pitx2 expression is lost (Matt et al.,
2005, 2008; Molotkov et al., 2006). Het-
erozygous mutations in human PITX2
are one genetic cause of Axenfeld-
Rieger Syndrome, which features ante-
rior segment defects and an associated
high risk for early-onset glaucoma
(Semina et al., 1997; Alward, 2000).
An important downstream target of
PITX2 is Dkk2, which encodes an
extracellular antagonist of canonical
Wnt/b-catenin signaling. DKK2 is
required to moderate Wnt/b-catenin
signaling activity in both the neural
crest and overlying surface ectoderm
of the anterior segment (Gage et al.,
2008). Collectively, these observations
implicate PITX2 as an important inte-
gration node between these two major
signaling pathways during eye devel-
opment (Gage et al., 2008; Gage and
Zacharias, 2009; Kumar and Duester,
2010). In addition, PITX2, b-catenin,
and LEF-1 interact synergistically to
regulate the Lef1 promoter, further
strengthening the connection between
PITX2 and canonical Wnt signaling
(Vadlamudi et al., 2005).
Pitx2 itself has been implicated as a
transcriptional target of canonical
Wnt/b-catenin signaling in the devel-
oping pituitary gland through sequen-
ces located 50 (Kioussi et al., 2002)
and 30 (Ai et al., 2007) of the gene. Ca-
nonical Wnt signaling may also play a
role in post-transcriptional stabiliza-
tion of the Pitx2 mRNA (Briata et al.,
2003). Treatment of embryos with
LiCl, an agonist of canonical Wnt sig-
naling, stimulates expression of Pitx2
within the periocular mesenchyme
(Kioussi et al., 2002). In addition,
PITX2 protein levels remain persis-
tently high in the ocular neural crest
of Dkk2-deficient mice, providing evi-
dence for an auto-regulatory feedback
loop (Gage et al., 2008). Although the
precise mechanism underlying this
expression change is not known, these
data also suggested that a combinato-
rial code including both RA and ca-
nonical Wnt/b-catenin signaling may
be required to activate Pitx2 expres-
sion in the neural crest.
In this report, we present evidence
that canonical Wnt/b-catenin signal-
ing is not required for initial activa-
tion of Pitx2, but it is required for
maintenance of its continued expres-
sion, likely via direct binding of Lef-1
and b-catenin to the Pitx2 promoter.
Thus, the two signaling pathways do
contribute to a code required for nor-
mal Pitx2 expression but they act
sequentially, rather than in concert.
Transient expression of Pitx2 is suffi-
cient to activate a genetic program that
is required to anchor the anterior optic
cup/lens to the overlying surface ecto-
derm. Finally, the dependence of Pitx2
expression upon canonical Wnt/b-cate-
nin signaling appears to be unique
among a panel of known regulators of
early anterior segment development.
RESULTS
Neural Crest–Specific Loss of
b-Catenin Is Efficient and
Does Not Notably Alter Early
Eye Development
b-catenin is expressed throughout the
tissues of the developing eye, includ-
ing the neural crest, through the pe-
riod during which Pitx2 expression is
activated (Fig. 1A). This expression
pattern was consistent with the possi-
bility that intact responsiveness to ca-
nonical Wnt/b-catenin signaling by
the neural crest might be required for
activation of Pitx2 in these cells, as
well as more generally for normal eye
development during this stage.
To test these hypotheses, we gener-
ated mice lacking b-catenin in neural
crest by mating mice carrying the
conditionally null Ctnnb1tm2Kem allele
(Brault et al., 2001) with mice trans-
mitting the neural crest-specific
Wnt1Cre1 transgene (Danielian et al.,
1998). Since b-catenin is the essential
downstream effector of the pathway,
this genetic approach very efficiently
and comprehensively prevents neural
crest in these mice from responding
to canonical Wnt signaling (Brault
et al., 2001). However, the effects of
ablating b-catenin on eye develop-
ment were not previously described
(Brault et al., 2001) b-catenin is unde-
tectable in neural crest of Ctnnb1-
ncko (Wnt1Cre;Ctnnb1tm2Kem/tm2Kem)
embryos at e10.5 (Fig. 1E). Eyes of
the mutant embryos are grossly nor-
mal at this time point (Fig. 1B vs. F),
indicating that intact Wnt signaling in
neural crest is not required for their
migration into the eye field and may
not be required for early stages of eye
morphogenesis. In contrast, neural
crest in mutants with constitutively
activated b-catenin does not efficiently
populate the developing eye (data not
shown) (Lee et al., 2004). Ctnnb1-ncko
eyes begin to exhibit a thick, neuroblas-
tic optic stalk that is different from
wild type controls and a modest misor-
ientation of the optic cup towards the
ventral side by e11.5 (Fig. 1C vs. G).
These features are more accentuated
by e12.5, when the optic stalk remains
abnormally thick and contiguous with
the ventral diencephalon, which is dis-
placed peripherally, and the optic cup
is rotated ventrally (Fig. 1D vs. H). Col-
lectively, these data suggest that the
overt requirement for Wnt/b-catenin
responsiveness in neural crest begins
at approximately e11.5 during mouse
eye development.
Canonical Wnt/b-Catenin
Signaling Is Required for
Maintenance of Pitx2
Expression in Neural Crest
We next assessed whether intact canon-
ical Wnt/b-catenin signaling is required
for activation or maintenance of Pitx2
expression in neural crest by immuno-
staining Ctnnb1-ncko embryos for both
b-catenin and PITX2. Activation of the
R26R Cre reporter locus (Soriano,
1999) was used to fate map neural
crest in the mutant eyes and to















Fig. 1. Loss of b-catenin protein and analy-
sis of early eye morphogenesis in Ctnnb1-
ncko mice. A, E: Eye sections of e10.5 control
and Ctnnb1-ncko littermates were stained for
detection of b-catenin by immunofluorescence
(green) and imaged with DAPI (blue) to visual-
ized nuclei. Note how the mesoderm-derived
endothelial cells of blood vessels (<) stand
out in Ctnnb1-ncko mice due to the efficient
loss of b-catenin in surrounding neural crest.
B–D: Eye sections of control embryos at the
indicated ages were stained by H&E to visual-
ize eye morphogenesis. F–H: Eye sections of
Ctnnb1-ncko littermates of wild type embryos
in B–D were stained by H&E to visualize eye
morphogenesis. r, retina; l, lens; n, neural
crest; <, blood vessel; os, optic stalk. Scale
bar ¼ 100 mm.
Fig. 2. PITX2 protein expression in Ctnnb1-
ncko versus control eyes during early eye de-
velopment. b-catenin (green) and PITX2 (red)
protein expression were detected by double
immunofluorescence on eye sections taken
from Ctnnb1-ncko and control littermates at
the indicated time points. Overall PITX2
expression is comparable in the two geno-
types at e10.5 but is rapidly reduced (e11.5)
and then lost (e12.5) specifically in neural
crest cells of Ctnnb1-ncko eyes. Mesoderm
expression of PITX2 is unaffected in the
mutants. r, retina; l, lens; c, cornea; n, neural
crest; m, mesoderm.













confirm comprehensive loss of b-cate-
nin in these cells (data not shown).
The overall pattern of PITX2 expres-
sion in eyes of Ctnnb1-ncko embryos,
including in neural crest lacking b-cat-
enin, is indistinguishable from control
littermates at e10.5, although levels of
PITX2 expression sometimes appear
diminished in individual neural crest
cells (Fig. 2A–D). PITX2 expression is
still detectable but dramatically
reduced in neural crest of Ctnnb1-ncko
mice compared to control littermates
at e11.5 (Fig. 2E–H). By e12.5, PITX2
expression is undetectable in neural
crest of Ctnnb1-ncko embryos but
high-level expression is observed in
neural crest surrounding eyes of con-
trol littermates (Fig. 2I–L). Mesoderm
expression appears to be unaffected in
Ctnnb1-ncko eyes at any timepoint
examined (Fig. 2).
We considered the possibility that
intact canonical Wnt/b-catenin signal-
ing could be required for survival of
neural crest and that the apparent loss
of PITX2 expression might result from
the death of these cells. In addition to
Pitx2flox, mutant animals also carried
the R26R reporter allele, allowing us
to fate map neural crest following Cre-
mediated activation of lacZ (Soriano,
1999). Neural crest expressing lacZ
are abundant in Ctnnb1-ncko eyes
throughout the relevant developmen-
tal stages (Fig. 3A,D). Consistent with
this finding, TUNEL assays detected
no differences in apoptotic cell death
in mutant versus control littermate
eyes (Fig. 3B,C,E,F). Altogether, these
data indicate that maintenance of
PITX2 expression in neural crest dur-
ing eye development requires intact
canonical Wnt/b-catenin signaling.




A functional TCF/LEF-responsive ele-
ment is located 200-bp 50 to the pro-
moter for the Pitx2a and Pitx2b
mRNA isoforms (Fig. 4A) (Kioussi
et al., 2002). This element is con-
served between mice and humans,
and is active in cells lines from the
anterior pituitary gland (Kioussi
et al., 2002). A second functional TCF/
LEF-responsive element is present
within an enhancer located 30 to the
Pitx2 gene and is required for in vivo
enhancer activity within Rathke’s
pouch, the embryonic precursor to the
anterior pituitary gland (Ai et al.,
2007). However, the potential rele-
vance of these elements to Pitx2
expression in periocular mesenchyme
has not been explored.
To determine whether either of the
two previously identified TFC/LEF-re-
sponsive elements are occupied during
eye development, we performed chro-
matin immunoprecipitation on perioc-
ular mesenchyme derived from e12.5
embryos. These assays revealed that
Pitx2 promoter sequences containing
the TCF/LEF-responsive element are
significantly enriched over back-
ground levels in samples immunopre-
cipitated with antibodies specific to ei-
ther b-catenin or LEF1 (Fig. 4B). In
contrast, neither sequences spanning
the TCF/LEF-responsive element
located within the 30 enhancer, nor
sequences within a Pitx2 intron that
are not associated with a potential
TCF/LEF site, were enriched by
immunoprecipitation with the specific
antibody (see Supp. Fig. S1, which is
available online). These data indicate
that the TCF/LEF-responsive element
within the 50 Pitx2 promoter sequen-
ces is physically occupied by b-catenin
and LEF1 in periocular mesenchyme
and suggest that canonical Wnt sig-
naling acts directly through this site
to maintain Pitx2 expression in these
cells during development.
Transient Expression of Pitx2
Is Sufficient to Rescue
Initiation of Anterior
Segment Development
The optic stalk of wild type eyes elon-
gates as development proceeds and
the optic cup remains in intimate con-
tact with the overlying surface ecto-
derm (Fig. 5A). In contrast, global or
neural crest-specific Pitx2 knockout
mice exhibit severe defects including
a thickened and substantially short-
ened the optic stalk, as well as dis-
placement of the optic cup to a mid-
line position substantially removed
from the overlying ocular surface
ectoderm (Fig. 5B) (Gage et al., 1999;
Kitamura et al., 1999; Evans and
Gage, 2005). We have previously
hypothesized that displacement of the
optic cup in Pitx2 mutant mice results
primarily from the foreshortened
optic stalk ‘‘pulling’’ the optic cup
towards the midline and away from
the surface ectoderm (Evans and
Gage, 2005). However, optic cups of
Ctnnb1-ncko mice are appropriately
positioned directly beneath the over-
lying ocular surface ectoderm, despite
the fact that morphogenesis of the
optic stalk appears to be disrupted at
least as severely in these animals as
in Pitx2 mutant mice (Fig. 5C). This
raised the possibility that transient
expression of Pitx2 in Ctnnb1-ncko
mice is sufficient to activate a genetic
program required to anchor the optic
cup/lens to the overlying ocular sur-
face ectoderm.
We tested this hypothesis by per-
forming temporal knockouts of Pitx2
(Pitx2-tko) in mice carrying our condi-
tional Pitx2flox allele (Gage et al.,
1999) and UBC-CreER (Gruber et al.,
2007). The Cre-ER fusion protein
required to delete Pitx2 is ubiqui-
tously expressed by this transgene
but is functionally inactive except in
the presence of tamoxifen (Gruber
et al., 2007). In animals with the
genotype UBC-CreER;Pitx2flox/flox,
injection of timed pregnant dams with
tamoxifen resulted in complete loss of
PITX2 protein within 24 hr (see Supp.
Fig. S2, which is available online).
We, therefore, injected timed preg-
nant dams from the appropriate mat-
ings with tamoxifen at e10.5, which
permitted normal activation but
resulted in the loss of all PITX2 pro-
tein by e11.5, a time course similar to
that observed in Ctnnb1-ncko mice.
In contrast to global or neural crest–
specific Pitx2 knockout eyes (Fig. 5B
and data not shown), the eyes of Pitx2
mutant mice are located peripherally,
similar to, although not identical to the
eyes of wild type and Ctnnb1-ncko
mice (Fig. 5D). The corneal mesen-
chyme of e14.5 Pitx2-tko eyes is signifi-
cantly thicker than that found in wild
type or Ctnnb1-ncko eyes, an early
manifestation of the severe corneal
defects found in these mice at later
time points (data not shown). The
Pitx2-tko eyes are connected to the lat-
eral diencephalon by an optic stalk
that is thickened and shortened rela-
tive to wild type eyes (Fig. 5A vs. 5D),
a defect that appears similar to what
we have reported previously for global













and neural crest–specific Pitx2 knock-
out eyes (Gage et al., 1999; Evans and
Gage, 2005). The observation that
Ctnnb1-ncko and Pitx2-tko eyes are
located peripherally, despite significant
defects in development of the optic
stalk, indicates that the elongation of
the optic stalk alone cannot determine
placement of the optic cup and lens.
Rather, these data suggest a model
wherein early expression of PITX2 pro-
tein at e10.5–11 also activates a pro-
gram of adhesion that facilitates a sta-
ble interaction between the anterior
optic cup, the lens, the anterior seg-
ment mesenchyme, and the overlying
ocular surface ectoderm.
Other Regulators of Anterior
Segment Development Do Not
Depend on Canonical Wnt
Signaling in Ocular
Neural Crest
Foxc1, Foxc2, and Tfap2b each encode
transcription factors that are essen-
Fig. 3. b-catenin is not required for survival of ocular neural crest. A,D: Survival of neural crest
mesenchyme in Ctnnb1-ncko eyes at the indicated time points is demonstrated by using immu-
nofluorescence to detect b-galactosidase expressed following Cre-mediated activation of the
R26R reporter allele. B,C,E,F: Apoptotic cells in Ctnnb1-ncko and control littermates at the indi-
cated time points as detected by TUNEL assay. No difference in TUNEL-positive cells is
observed between the two genotypes. r, retina; l, lens; c, cornea; n, neural crest; m, mesoderm.
Note: The image in A is taken from a section adjacent to the image in Figure 2A and the image
in D is taken from a section adjacent to the image in Figure 2E.
Fig. 4. b-catenin and LEF1 physically asso-
ciate with Pitx2 promoter sequences. A: Sche-
matic illustrating location of conserved TCF/
LEF-responsive element located 200-bp
upstream of the 50 Pitx2 promoter. Modified
from Kioussi et al. (2002). B: ChIP analysis on
primary cultures of mesenchyme grown from
wild type e12.5 eye primordia with specific
antibodies, normal control sera, water, and
sheared input DNA. Specific PCR product (*)
is significantly enriched in samples immuno-
precipitated with rabbit anti-b-catenin and
mouse anti-LEF1 antibodies as compared
with the normal rabbit serum (NRS) and nor-
mal mouse serum (NMS), respectively, indicat-
ing physical association of b-catenin and
LEF1 with the Pitx2 promoter sequences in
cells derived from periocular mesenchyme.
Fig. 5. Comparison of eye phenotypes in Pitx2 and Ctnnb1 mutant mice. Transverse sections of
eyes from e14.5 embryos with the indicated genotypes were stained with hematoxylin and eosin.
Images of each genotype were taken at the same magnification. l, lens; e, surface ectoderm.













tial in the ocular neural crest for nor-
mal anterior segment development
and function. We analyzed the expres-
sion of these genes in Ctnnb1-ncko
mice to determine whether their
expression in neural crest might
require intact canonical Wnt/b-cate-
nin signaling and because the results
could provide insight into the extent
to which initial patterning of the an-
terior segment might be disrupted in
these mice.
The forkhead transcription factor
gene, Foxc1, is required for anterior
segment development in mice, and
mutations in human FOXC1 are a
second genetic cause of Axenfeld-
Rieger Syndrome (Mears et al., 1998;
Lehmann et al., 2000, 2003). Like
Pitx2, retinoic acid signaling is also
required to activate Foxc1 expression
in the ocular neural crest (Matt et al.,
2005, 2008; Molotkov et al., 2006).
FOXC1 protein is normally expressed
in neural crest of the periocular mes-
enchyme and in the surface ectoderm
of the palpebral conjunctiva and pal-
pebral epidermis in the eyelid (Fig.
6A,C) (Kume et al., 2000; Gage et al.,
2008). This expression pattern within
the anterior segment is unchanged in
Ctnnb1-ncko mice at e12.5 and e14.5,
suggesting that Foxc1 expression
within these structures of the eye is
not dependent on canonical Wnt sig-
naling (Fig. 6B,D). However, FOXC1
protein levels are diminished in mes-
enchyme adjacent to the optic cup and
normally fated to become sclera in the
Ctnnb1-ncko mutants. However, the
sclera is absent in Ctnnb1-ncko eyes.
Therefore, its not clear whether this
loss of Foxc1 expression is a direct
result of inactivating canonical Wnt
signaling in these cells or an indirect
result of losing scleral specification,
which requires Pitx2 expression in
neural crest (Evans and Gage, 2005).
Mutations in Foxc2/FOXC2 cause
distichiasis (extra eyelashes) in mice
and humans, as well as additional an-
terior segment defects in mice (Smith
et al., 2000; Kriederman et al., 2003).
In developing wild type eyes, FOXC2
protein is initially expressed in the
neural crest surrounding the optic
cup, but expression in corneal neural
crest is down-regulated by e12.5 and
beyond (Fig. 6E,G) (Kidson et al.,
1999; Gage et al., 2008). FOXC2 is
also expressed in surface ectoderm of
the palpebral conjunctiva (Fig. 6E,G)
(Gage et al., 2008). These expression
patterns are conserved in both the
neural crest and palpebral conjunc-
tiva of Pitx2 mice, suggesting that ini-
tial patterning of anterior segment
structures is not completely lost in
these mutants and Foxc2 does not
appear to be regulated by canonical
Wnt signaling (Fig. 6F,H).
Tfap2b encodes an AP-2 family
transcription factor whose expression
from e12.5–14.5 marks neural crest of
the corneal, limbal, and conjunctival
mesenchyme, as well as surface ecto-
derm of the presumptive conjunctiva
and eyelid (Fig. 6I,K). These expres-
sion patterns are retained in Ctnnb1-
ncko mice (Fig. 6J,L), providing fur-
ther evidence that initial patterning
of anterior segment structures is not
completely lost in these mutants.
DISCUSSION
Inappropriately low or high levels of
PITX2 activity lead to anterior seg-
ment defects in mice and humans
(Semina et al., 1996; Kozlowski and
Walter, 2000; Priston et al., 2001;
Holmberg et al., 2004), indicating that
tight control of Pitx2 in time and space
is a prerequisite for normal eye devel-
opment and function. Similar control
of Pitx2 expression is required for nor-
mal development of organs such as the
pituitary gland, craniofacial struc-
tures, and heart but the underlying
mechanisms regulating expression in
any of these structures are not well
defined. In the present study, we
extend our understanding of the mo-
lecular requirements leading to nor-
mal Pitx2 expression during eye devel-
opment, information that may have
relevance in other tissues and organs.
Normal Pitx2 Expression in
Ocular Neural Crest Is the
Net Response to Inputs From
Multiple Signaling Pathways
Pitx2 is not expressed in neural crest
migrating to the eye primordia.
Rather, retinoic acid directly activates
Pitx2 expression in neural crest after
arrival of these cells in the developing
eye field (Fig. 7) (Matt et al., 2005,
2008; Molotkov et al., 2006; Kumar
and Duester, 2010). The anterior optic
cup, lens vesicle, and ocular surface
ectoderm are the sources of the reti-
noic acid, providing an effective
means for stimulating Pitx2 activa-
tion only within neural crest adjacent
to the developing eye. The action of
retinoic acid on the neural crest is
direct as demonstrated by neural
crest–specific ablation of the appro-
priate nuclear receptors (Matt et al.,
2005, 2008). Recently, a DR5 RA
response element that binds all three
RA receptors in the developing eye
was identified upstream of Pitx2, sup-
porting the idea that Pitx2 is a direct
RA target (Kumar and Duester,
2010). The competence of neural crest
to activate Pitx2 in response to reti-
noic acid appears to be transient and
ends within days of the stage when
Pitx2 is normally first expressed (See
and Clagett-Dame, 2009). Therefore,
a second mechanism likely underlies
persistent Pitx2 expression within the
neural crest, a fact that fits well with
the data presented herein.
We tested the potential require-
ments for canonical Wnt signaling ac-
tivity on Pitx2 expression in ocular
neural crest. Unlike retinoic acid sig-
naling, canonical Wnt/b-catenin sig-
naling is not required for activation of
Pitx2, as initial expression in Ctnnb1-
ncko mice is comparable to control lit-
termates. In contrast, Pitx2 expres-
sion rapidly diminishes and is soon
lost in ocular neural crest of Ctnnb1-
ncko mice. We conclude that intact ca-
nonical Wnt/b–catenin signaling is
required for maintenance of Pitx2
expression in neural crest but is not
sufficient for activation in these cells
(Fig. 7). The action of Wnt signaling
appears to be direct as a functional
TCF/LEF site within the Pitx2 pro-
moter is occupied by LEF-1 and b-cat-
enin in ocular neural crest. Collec-
tively, we propose a model in which a
serial code of signaling pathways is
required for normal overall Pitx2
expression in ocular neural crest,
with retinoic acid required for activa-
tion and canonical Wnts subsequently
required for maintained expression
(Fig. 7). As with retinoic acid, the ocu-
lar surface ectoderm and optic cup are
likely to be the sources of Wnt ligands
(Liu et al., 2003).
Modulation of canonical Wnt/b-cat-
enin signaling activity levels also
mediates net local PITX2 protein lev-
els over time in the developing and













mature eye (Fig. 7) (Gage et al.,
2008). Most Axenfeld-Rieger cases
linked to PITX2 arise via a haploin-
sufficiency mechanism, although an
apparent gain-of-function mutation
has also been reported (Kozlowski
and Walter, 2000; Priston et al.,
2001). Over-expression of PITX2 also
results in features of Axenfeld-Rieger
in mice, including corneal opacifica-
tion, corneal hypertrophy, and irido-
corneal adhesions (Holmberg et al.,
2004). Therefore, the ability to ulti-
mately control and fine-tune PITX2
protein levels through modulation of
canonical Wnt signaling activity is
likely critical for normal eye develop-
ment in humans and mice. Additional
negative regulators of canonical Wnt
signaling are expressed in the develop-
ing and mature eye (Chow and Lang,
2001; Chen et al., 2004; Diep et al.,
2004; Fjeld et al., 2005). Although
their effects on PITX2 expression lev-
els have not been tested, it may be
that the net effects of DKK2 and addi-
tional negative regulators on canonical
Wnt signaling activity provide a key
mechanism for providing temporal
and spatial control over PITX2 protein
Fig. 6. Additional transcription factor expression in Ctnnb1-ncko versus control eyes. Eye sections of control and Ctnnb1-ncko littermates at the
indicated developmental stages were immunostained to detect expression of the transcription factors, FOXC1 (A–D), FOXC2 (E–H), or TFAP2B
(I–L). For each, expression in neural crest mesenchyme and surface ectoderm was independent of b-catenin function in the neural crest.













levels once the Pitx2 gene is initially
activated by retinoic acid.
It appears that complex regulation
is a general feature of Pitx2 expres-
sion in multiple tissues, as initiation
and maintenance of asymmetric Pitx2
expression in the left lateral plate
mesoderm is also dependent upon a
two-step process (Shiratori et al.,
2001). Regulation of expression at
multiple steps and, potentially by di-
vergent mechanisms in different line-
ages as development proceeds, likely
provides advantages over more simple
forms of regulation. In the eye, RA sig-
naling activates Pitx2 expression
within a large pool of neural crest cells
that are subsequently fated to gener-
ate multiple mature tissues over the
course of eye development, including
corneal stroma, corneal endothelium,
and trabecular meshwork. Local and
temporal differences in the signaling
environment may determine whether
Pitx2 expression is maintained, and at
what levels, conditions that likely
have a profound effect on fate deci-
sions undertaken by individual cells.
Inputs from other signaling path-
ways, in addition to retinoic acid and
Wnts, are likely to contribute to the
code required to achieve appropriate
temporal and spatial Pitx2 expression
levels during eye development. Hedge-
hog appears to be a third component of
the signaling code required to main-
tain Pitx2 expression during eye devel-
opment. At e12.5, Pitx2 expression is
largely equivalent between Ihh/
eyes and those of control littermates
(Dakubo et al., 2008). By e13.5, how-
ever, Pitx2 expression is lost from mes-
enchyme located at the posterior and
periphery of Ihh/ eyes, establishing
that hedgehog signaling is required to
maintain Pitx2 expression within the
subset of periocular mesenchyme fated
to contribute the scleral coating
(Dakubo et al., 2008). Notably, hedge-
hog signaling is not sufficient to acti-
vate Pitx2 expression indicating that
this step is mediated by retinoic acid
or another signaling pathway. There-
fore, in posterior periocular mesen-
chyme, loss of hedgehog and canonical
Wnt signaling has similar consequen-
ces, suggesting that the two pathways
may act in parallel, a possibility that
should be experimentally tested. How-
ever, hedgehog signaling is not
required to maintain Pitx2 expression
in the anterior segment, indicating
that there are clear differences in the
requirements for the two pathways,
depending upon the cellular position
within the eye primorium (Dakubo
et al., 2008). This provides further
evidence that overall regulation of
Pitx2 expression in these cells is
accomplished by a multistep mecha-
nism. TGF-b signaling has also been
implicated in Pitx2 expression within
anterior segment neural crest but the
functions of this pathway with respect
to early development are unclear (Itt-
ner et al., 2005).
The requirement for intact canoni-
cal Wnt signaling activity in ocular
neural crest is not shared by several
other key transcription factors in an-
terior segment development. The
inclusion of Foxc1 in this group is par-
ticularly surprising since it shares
many features with Pitx2, including a
dependence on retinoic acid signaling
for its activation and Indian hedgehog
for persistent expression in peripheral
and posterior mesenchyme (Matt
et al., 2005, 2008; Molotkov et al.,
2006; Dakubo et al., 2008). Alterations
in Foxc1/FOXC1 gene dose lead to
Axenfeld-Rieger Syndrome in humans
and cause anterior segment defects in
mice. This indicates that achieving
appropriate FOXC1 activity levels is a
prerequisite for normal eye develop-
ment and, similar to PITX2, they are
likely subject to tight temporal and spa-
tial control(s) (Mears et al., 1998; Leh-
mann et al., 2000; Smith et al., 2000).
However, despite the implication of
common regulatory mechanisms sug-
gested by these functional similarities,
it does not appear that a requirement
for canonical Wnt signaling activity for
maintenance of Foxc1/FOXC1 expres-
sion is among the similarities.
Roles for Canonical Wnt
Signaling in the Neural Crest
During Early Eye
Morphogenesis
Canonical Wnt signaling has the
capacity to control many functions in
neural crest fated to contribute ocular
tissues, including induction, migra-
tion, cell survival, cell proliferation,
and differentiation. Our data suggest
that intact canonical Wnt signaling is
not required for migration of neural
crest to the eye primordia, as these
cells populate early Ctnnb1-ncko eyes
at a level comparable to control eyes.
Similarly, intact canonical Wnt sig-
naling appears to be dispensable for
early eye morphogenesis from the
neural and surface ectoderm, as the
optic cup and lens vesicle are grossly
normal in Ctnnb1-ncko mutants at
e10.5. Therefore, we conclude that the
earliest stages of eye development do
not require competence of the neural
crest to respond to canonical Wnt
signaling.
In contrast, Ctnnb1-ncko eyes begin
to exhibit morphological differences
from control littermates by e11.5,
when deviations in the cornea, orien-
tation of the optic cup, and the optic
Fig. 7. Model for regulation of Pitx2 expression in the anterior segment by retinoic acid and
Wnt signaling. Phase I: Pitx2 expression is initiated by retinoic acid signaling produced by the
anterior optic cup, anterior lens vesicle, and surface ectoderm. Phase II: Pitx2 expression is
maintained by canonical Wnt signaling produced by the surface ectoderm. Phase III: Pitx2
expression levels are reduced to lower steady-state levels due to inhibition of canonical Wnt sig-
naling activity by DKK2.













stalk first become apparent. These
phenotypes are enhanced over the
next several days and are followed by
agenesis of the sclera and eyelids. The
initial emergence of these phenotypes
correlates strongly with the timing of
loss of Pitx2 expression. In addition,
these phenotypes encompass many of
the phenotypes observed in Pitx2 mu-
tant mice (Gage et al., 1999; Evans
and Gage, 2005). Collectively, these
data suggest that maintenance of
Pitx2 expression is an important early
functional target of canonical Wnt sig-
naling activity in the neural crest
during eye development.
Development of the cornea, optic
cup, and optic stalk are complex proc-
esses and must be regulated by many
factors and pathways. Therefore, it
was somewhat surprising that none of
the other key regulators of eye devel-
opment that we tested were dependent
on canonical Wnt signaling for their
expression. This was likely due to the
fact that we only tested a small num-
ber of genes that had previously been
identified as important transcriptional
regulators of anterior segment devel-
opment, comparable to Pitx2. We
expect that canonical Wnt signaling
regulates the expression and function
of additional genes in the ocular neu-
ral crest that are required for eye de-
velopment, and that these will be
revealed in the future using more
open-ended, unbiased approaches. Dis-
covery of these genes and ascertaining
their functions are prerequisites for a






The optic cups in global and neural
crest–specific Pitx2 mutant eyes are
displaced a considerable distance from
the surface ectoderm (Gage et al.,
1999; Evans and Gage, 2005), whereas
eyes of Ctnnb1-ncko mice are located in
the wild type position at the periphery
of the head, immediately beneath the
surface ectoderm. Transient expression
of Pitx2 in temporal knockout mice also
largely rescues the displaced optic cup
and lens phenotypes of global and neu-
ral crest–specific Pitx2 mutant mice,
permitting them to remain localized
beneath the surface ectoderm in associ-
ation with the presumptive corneal epi-
thelium. Collectively, these data sug-
gest that early Pitx2 expression in the
neural crest activates a mechanism for
bonding anterior segment elements to-
gether, maintaining the position of
these elements relative to each other
as the head grows rapidly in size dur-
ing development. This bonding mecha-
nism likely works in concert with the
Pitx2-dependent signaling that is
required for optic stalk extension
(Evans and Gage, 2005).
The molecular mechanism(s) con-
tributing to this process remains to
be determined. At an earlier stage of
eye development, during formation of
the optic cup and lens vesicle, con-
tractile filopodia tether the presump-
tive lens to the retina via a Cdc42-
and IRSp53-dependent mechanism,
providing a method for coordinated
evagination between the two epithe-
lial layers (Chauhan et al., 2009).
This raises the possibility that early
expression of Pitx2 may activate simi-
lar connections between the anterior
optic cup, lens, neural crest, and sur-
face ectoderm during the subsequent
phase of eye development. Alterna-
tively, Pitx2 may activate expression
of adhesive extracellular matrix mole-
cules, such as integrins or collagens
that bond together the various tissue
components. Further work will be







Generation of alleles for Cre-mediated
inactivation of Ctnnb1 (Ctnnb1tm2Kem)
(Brault et al., 2001) and Pitx2 (Pitx2flox)
(Gage et al., 1999), or Cre-mediated
activation of a lacZ reporter (R26Rflox)
was described previously (Soriano,
1999). Transgenic mice expressing Cre
under the control of the Wnt1 promoter
(Wnt1-Cre) were obtained from A.
McMahon (Danielian et al., 1998).
Transgenic mice expressing a tamoxi-
fen-inducible form of Cre (Cre-ERT2)
under the control of the ubiqui-
tously expressed UBC promoter
(Ubc-CreERT2) were obtained from
The Jackson Laboratories (Bar Har-
bor, ME) (Gruber et al., 2007; Ruzan-
kina et al., 2007). The Wnt1-Cre;
Ctnnb1þ/tm2Kem parental line was gen-
erated by mating Wnt1-Cre and
Ctnnb1tm2Kem mice. The Ubc-CreERT2;
Pitx2þ/null parental line was generated
by mating Ubc-CreERT2 and Pitx2null
mice. Mice were maintained as sepa-
rate breeding colonies at the University
of Michigan. All procedures involving
mice were approved by the University
of Michigan Committee on Use and
Care of Animals. All experiments were
conducted in accordance with the prin-
ciples and procedures outlined in the
NIH Guidelines for the Care and Use
of Experimental Animals.
Wnt1-Cre; Ctnnb1þ/tm2Kem mice
were mated to Ctnnb1tm2Kem/tm2Kem;
R26Rflox/flox mice to generate timed
pregnancies for neural crest–specific
Ctnnb1 knockout mice, designating
the day after mating as embryonic
day 0.5. Embryos were collected by
caesarian section at the appropriate
stages, after euthanasia of the
mother. The resulting embryos were
genotyped for Cre (Gage et al.,
2005), Ctnnb1 (Brault et al., 2001),
or R26R (Soriano, 1999) using PCR-
based methods. Embryos with a
Wnt1-Cre; Ctnnb1tm2Kem/tm2Kem geno-
type were considered mutant, while
Ctnnb1þ/tm2Kem or Ctnnb1tm2Kem/tm2Kem
embryos lacking the Wnt1-Cre trans-
gene were used as controls.
Ubc-CreERT2; Pitx2þ/null mice were
mated to Pitx2flox/flox;R26Rflox/flox
mice to generate timed pregnancies
for temporal-specific Pitx2 knockout
mice, designating the day after mat-
ing as embryonic day 0.5. A single in-
traperitoneal injection of tamoxifen
(Sigma, St. Louis, MO; T5648-1G)
suspended in corn oil at a dose of 100
mg per gram of body weight was
administered to the pregnant dam at
noon on e10.5. Embryos were col-
lected on either e11.5 or e14.5 by cae-
sarian section after euthanasia of the
mother. The resulting embryos were
genotyped for Cre (Gage et al., 2005),
Pitx2 (Gage et al., 1999), or R26R
(Soriano, 1999) using PCR-based
methods. Embryos with a Ubc-
CreERT2; Pitx2flox/null genotype were
considered mutant. Embryos with the
genotype Pitx2þ/flox were considered
wild type controls while embryos with

















All embryos were fixed in 4% parafor-
maldehyde in PBS, washed, dehy-
drated, and processed for sectioning in
Paraplast Plus (McCormick Scientific;
St. Louis, MO). Mounted paraffin sec-
tions for morphological analysis were
dewaxed, rehydrated, and stained
with hematoxylin and eosin.
Immunofluorescence
Paraffin sections were dewaxed and
treated for antigen retrieval by boil-
ing for 10 min in 10 mM citrate buffer
(pH 6.0). Sections were treated with
Image-iT FX signal enhancer (Molecu-
lar Probes; Eugene, OR) for 30 min. Im-
munostaining was performed according
to standard protocols. Briefly, sections
were incubated with primary antibod-
ies against FoxC1, FoxC2 (Abcam;
Cambridge, MA), TFAP2B (Novus
Biologicals; Littleton, CO), b-catenin
(Santa Cruz Biotechnology; San
Diego, CA), b-galactosidase (kind gift
from Tom Glaser), and PITX2 (Hjalt
et al., 2000). Treatment with the
primary antibody was followed with
biotinylated species-specific secondary
antibodies (Jackson Immuno Research;
West Grove, PA). Signals were detected
using tyramide signal amplification
kits (Molecular Probes; Eugene, OR).
Photography was performed on a Nikon
Eclipse 800 fluorescence microscope.
TUNEL Assay
Terminal dUTP nick end labeling
(TUNEL) was performed using an in
situ Cell Death Detection kit (Roche,
Indianapolis, IN) per manufacturer
protocol.
Primary Cell Isolation and
Chromatin Immunopreci-
pitation Assays
Eye primordia and surrounding mes-
enchyme microdissected from multiple
wild type e12.5 embryos were pooled
and cultured until primary mouse
fibroblasts (MEF) were obtained as
previously described (Crofford et al.,
1994). ChIP assays were performed on
the MEFs (passages 3 through 8) as
previously described (Gummow et al.,
2006). Specific immunoprecipitations
were performed using a rabbit polyclo-
nal antibody generated against b-cate-
nin (Santa Cruz; Santa Cruz, CA) or a
mouse monoclonal antibody generated
against LEF1 (Millipore; Temecula,
CA). Parallel control immunoprecipita-
tions were performed using normal
rabbit serum (Vector; Burlingame, CA)
or normal mouse serum (Millipore),
respectively. Immune complexes were
captured using a mix of protein A and
protein G beads (Active Motif; Carls-
bad, CA) and eluted DNA fragments
were purified with a QIAquick Spin
Kit (Qiagen; Valencia, CA). Purified
DNA was analyzed by PCR using
region-specific Pitx2 genomic primers
as described below. Water and sheared
input DNA were used as negative and
positive controls, respectively. Sequen-
ces spanning the TCF/LEF site within
the 50 Pitx2 promoter were amplified
using the forward and reverse primers
50-TTA GAA GGG GTT TGA CGC AC-
30 and 50-CCA CTA GGG CTG AGA
AGT GA-30, respectively. Sequences
spanning the TCF’LEF site within the
30 enhancer were used as described
previously (Ai et al., 2007).
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